The Strong Defense
You Deserve
Massachusetts Pharmaceutical Firm To Pay Feds $20 Million To Dismiss Medicare Fraud Claims
A Massachusetts-based pharmaceutical firm has agreed to pay the Federal government over $20 million to settle claims by the U.S. Food and Drug Administration that it led doctors to make claims to Medicare for prescribing their drug for a non-approved usage. Federal prosecutors say the firm's top management began to be aware that its drug was dramatically less effective against keratosis during shorter incubation times than it was for longer ones in early 2014. Although the FDA approved the drug for use in the more effective long-incubation applications, prosecutors say the firm began to...
